EUVIMEDEUVIMED entdecken
Crossref

Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy

Alexander S Thomas, Parisa Tehranifar, Wooil Kwon, Nupur Shridhar, Kazuki N Sugahara, Beth A Schrope, John A Chabot, Gulam A Manji, Jeanine M Genkinger, Michael D Kluger

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Alexander S Thomas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Gastrointestinal and Endocrine Surgery, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: The authors received no specific funding for this work.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Current guidelines for treatment for locally advanced pancreatic cancer recommend chemotherapy ± radiation, or radiation alone when multimodal therapy is contraindicated. In a subset of patients, guideline‐recommended treatment (GRT) achieves sufficient response to qualify for potentially curative resection. This study evaluated trends in treatment utilization and aimed to identify barriers to GRT.

Methods

Patients with clinical T4M0 disease in the National Cancer Database from 2010 to 2017 were included. Potential predictors were assessed by relative risk regression with Poisson distribution and compared by log‐link function.

Results

In total, 28 056 patients met the criteria. Among 17 059 (67.67%) patients treated primarily with chemotherapy, 41.19% also had radiation and 8.89% went onto resection. Many received no cancer‐directed treatment or failed to receive GRT. Another 710 patients had radiation (±surgery) without chemotherapy despite few contraindications to chemotherapy. Over time, patients were more likely to undergo resection after chemotherapy (aRR = 1.58; p < 0.0001) and less likely to have chemoradiation (aRR = 0.78; p < 0.0001) or go untreated (aRR = 0.90; p < 0.0001). Socioeconomic factors (race, education, income, and insurance status) affected the likelihood of receiving chemotherapy and surgery. Median overall survival (OS) was significantly improved for patients treated with chemotherapy and particularly in those patients who went on to receive RT or undergo surgical resection. OS was also longer for patients treated at high‐volume academic centers. Patients insured by Medicaid, Medicare, or those without insurance had worse OS.

Conclusions

Despite improvement over time, many patients go untreated. Clinical factors were influential, but the impact of vulnerable social standing suggests persistent inequity in access to care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansFemaleMaleAgedMiddle AgedUnited StatesCombined Modality TherapyPancreatectomy

Stichwörter der Autor:innen

access to careguideline recommended treatmenthealthcare utilizationpancreatic cancerpancreatic neoplasmssocioeconomic disparities in health

Autor:innen und Institutionen

  • Department of Surgery, Division of Gastrointestinal and Endocrine Surgery, Columbia University Irving Medical Center, New York, New York, USA.
  • Herbert Irving Comprehensive Cancer Center Cancer Population Science Program, New York, New York, USA.
  • Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Herbert Irving Comprehensive Cancer Center, New York, New York, USA.

Förderung

  • The authors received no specific funding for this work

Zitieren

APA

Thomas, A. S., Tehranifar, P., Kwon, W., Shridhar, N., Sugahara, K. N., Schrope, B. A., Chabot, J. A., Manji, G. A., Genkinger, J. M., & Kluger, M. D. (2024). Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27851

Vancouver

Thomas AS, Tehranifar P, Kwon W, Shridhar N, Sugahara KN, Schrope BA, et al. Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27851

BibTeX
@article{Thomas2024,
  author = {Thomas, Alexander S and Tehranifar, Parisa and Kwon, Wooil and Shridhar, Nupur and Sugahara, Kazuki N and Schrope, Beth A and Chabot, John A and Manji, Gulam A and Genkinger, Jeanine M and Kluger, Michael D},
  title = {Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27851}
}
Kostenlos starten →